ZA200904281B - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders - Google Patents
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersInfo
- Publication number
- ZA200904281B ZA200904281B ZA200904281A ZA200904281A ZA200904281B ZA 200904281 B ZA200904281 B ZA 200904281B ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 B ZA200904281 B ZA 200904281B
- Authority
- ZA
- South Africa
- Prior art keywords
- diabetes
- treatment
- receptor agonists
- metabolic disorders
- heterocyclic
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87790306P | 2006-12-28 | 2006-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200904281B true ZA200904281B (en) | 2010-08-25 |
Family
ID=40261614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200904281A ZA200904281B (en) | 2006-12-28 | 2007-12-27 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN101616586B (en) |
| AR (1) | AR064702A1 (en) |
| CL (1) | CL2007003841A1 (en) |
| TW (1) | TWI414523B (en) |
| ZA (1) | ZA200904281B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| DK2280704T3 (en) * | 2008-03-31 | 2015-06-29 | Cymabay Therapeutics Inc | Oxymethylenarylforbindelser and uses thereof |
| WO2011041154A1 (en) | 2009-10-01 | 2011-04-07 | Metabolex, Inc. | Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| WO2011134969A1 (en) * | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Ketoheteroarylpiperidine and ketoheteroarylpiperazine derivates as fungicides |
| EP2585048B1 (en) * | 2010-06-23 | 2018-04-11 | CymaBay Therapeutics, Inc. | Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| CN103467398B (en) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | Triazole amide compounds, and preparation method and application thereof in resisting diabetes |
| CN105960405B (en) * | 2014-01-06 | 2021-02-19 | 理森制药股份公司 | Glutaminase inhibitors |
| CA3032432A1 (en) | 2016-08-03 | 2018-02-08 | Charles A. Mcwherter | Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions |
| CN111072652B (en) * | 2018-10-19 | 2023-05-23 | 暨南大学 | Compounds for the treatment of diabetes and/or related disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1829718A (en) * | 2003-07-14 | 2006-09-06 | 艾尼纳制药公司 | Fused aryl and heteroaryl derivatives as metabolism modulators and prevention and treatment of disorders associated therewith |
| CN1898235A (en) * | 2003-12-24 | 2007-01-17 | 普罗西迪恩有限公司 | Heterocyclic derivatives as gpcr receptor agonists |
-
2007
- 2007-12-27 ZA ZA200904281A patent/ZA200904281B/en unknown
- 2007-12-27 CL CL2007003841A patent/CL2007003841A1/en unknown
- 2007-12-27 TW TW96150669A patent/TWI414523B/en not_active IP Right Cessation
- 2007-12-27 CN CN200780048023.8A patent/CN101616586B/en not_active Expired - Fee Related
- 2007-12-28 AR ARP070105977 patent/AR064702A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR064702A1 (en) | 2009-04-22 |
| TWI414523B (en) | 2013-11-11 |
| CN101616586A (en) | 2009-12-30 |
| TW200833688A (en) | 2008-08-16 |
| CN101616586B (en) | 2014-08-13 |
| CL2007003841A1 (en) | 2008-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0814294A2 (en) | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders. | |
| ZA200904281B (en) | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | |
| WO2007109135A3 (en) | Neuromedin u receptor agonists and uses thereof | |
| ZA200806510B (en) | Heterobicyclic sulfonamide derivatives for the treatment of diabetes | |
| EP1976377A4 (en) | Compounds for the treatment of metabolic disorders | |
| IL209666A0 (en) | Gip-based mixed agonists for treatment of metabolic disorders and obesity | |
| IL197001A0 (en) | Combination treatment for metabolic disorders | |
| EP1983972A4 (en) | Compounds for the treatment of metabolic disorders | |
| IL195203A0 (en) | Compounds for the treatment of metabolic disorders | |
| WO2007100535A3 (en) | Oxyntomodulin derivatives | |
| IL205381A0 (en) | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | |
| IL193800A0 (en) | Endothelin and endothelin receptor agonists in the treatment of metabolic diseases | |
| IL194189A0 (en) | Combination treatment of metabolic disorders | |
| IL192852A0 (en) | Compounds for the treatment of metabolic disorders | |
| EP2051732A4 (en) | Methods of diagnosis and treatment for metabolic disorders | |
| IL180721A0 (en) | Nicotinic receptor agonists for the treatment of inflammatory diseases | |
| IL197695A0 (en) | 3-amino-pyridine derivatives for the treatment of metabolic disorders | |
| IL191271A0 (en) | Adenosine a3 receptor agonists for the treatment of dry eye disorders | |
| IL211267A (en) | Oxadiazole derivatives and medicaments and use thereof for the treatment of diabetes | |
| IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
| IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
| EP2139320A4 (en) | Methods and compositions of derivatives of probucol for the treatment of diabetes | |
| IL195920A0 (en) | 3-(1h-indol-3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety | |
| IL192982A0 (en) | Compounds for the treatment of metabolic disorders | |
| HK1135690A (en) | 3-amino-pyridine derivatives for the treatment of metabolic disorders |